Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

20.86
Delayed Data
As of 3:59pm ET
 -0.46 / -2.16%
Today’s Change
9.89
Today|||52-Week Range
23.30
+42.68%
Year-to-Date

Today’s Trading

Previous close21.32
Today’s open21.29
Day’s range20.45 - 21.53
Volume242,474
Average volume (3 months)272,875
Market cap$873.1M
Dividend yield--
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+13.46%
Earnings growth (this year)+214.44%
Earnings growth (next 5 years)--
Revenue growth (last year)+191.62%
P/E ratio22.2
Price/Sales20.55
Price/Book5.32

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...-0.08-0.41%
CLVSClovis Oncology Inc+0.37+1.65%
EGRXEagle Pharmaceutical...+1.22+2.12%
SGYPSynergy Pharmaceutic...-0.22-4.78%
Data as of 3:59pm ET, 08/25/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$27.8M
Annual profit (last year)-$17.6M
Net profit margin-63.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Vice President-Finance &
Investor Relations
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts

Partner Offers

Search for Jobs